Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibit... by Lu, Shun, Prof, Wu, Lin, Prof, Jian, Hong, MD, Chen, Ying, Prof, Wang, Qiming, MD, Fang, Jian, Prof, Wang, Ziping, MD, Hu, Yanping, Prof, Sun, Meili, MD, Han, Liang, MD, Miao, Liyun, Prof, Ding, Cuimin, MD, Cui, Jiuwei, Prof, Li, Baolan, Prof, Pan, Yueyin, Prof, Li, Xingya, MD, Ye, Feng, MD, Liu, Anwen, Prof, Wang, Ke, MD, Cang, Shundong, MD, Zhou, Hui, MD, Sun, Xing, MD, Ferry, David, MD, Lin, Yong, MD, Wang, Shuyan, MD, Zhang, Wen, MD, Zhang, Chengli, MD

Get full text